Terán, E., Lozano, R., Rodríguez, C. A., Abad, M., Figuero, L., Muñoz, J. A., . . . Fonseca, E. PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2− breast cancer. Wiley.
Chicago Style (17th ed.) CitationTerán, Eduardo, et al. PIK3CA Mutational Status in Tissue and Plasma as a Prognostic Biomarker in HR+/HER2− Breast Cancer. Wiley.
MLA (9th ed.) CitationTerán, Eduardo, et al. PIK3CA Mutational Status in Tissue and Plasma as a Prognostic Biomarker in HR+/HER2− Breast Cancer. Wiley.
Warning: These citations may not always be 100% accurate.